Cormorant Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200,000	Closed	-$5.39M	–	76
2022 Q2	$5.39M	Buy	+200,000	New	+$5.39M	0.41%	50
2022 Q1	–	Sell	-100,000	Closed	-$3.86M	–	80
2021 Q4	$3.86M	Buy	+100,000	New	+$3.86M	0.23%	59